In a first-in-the-nation move, a Colorado panel voted to limit what health plans in the state will pay for a costly arthritis ...

(Colorado Newsline) Democratic leaders, health care providers and consumer advocates praised a Colorado board’s decision last week to cap the price of a prescription drug used to treat rheumatoid ...

In Amgen’s latest campaign for Enbrel, kids are speaking up. Two new TV commercials feature children talking about their parents’ painful arthritis and their worries about it. The “Being There” ...

A Colorado board voted to move forward with setting a price ceiling on the arthritis drug Enbrel on Friday, a first-in-the-nation step that raises questions about whether a single state can reduce ...

Tough talk and a swell of political scrutiny hasn’t stopped leading companies in biopharma from hiking prices on the world’s top drugs. In fact, as the inauguration proceeded in Washington, D.C., on ...

Shares of Amgen Inc. rose another 4.5% on Monday after gaining nearly 6% on Friday, when a U.S. judge upheld two patents related to the pharmaceutical company's best-selling drug Enbrel. The two ...

Please provide your email address to receive an email when new articles are posted on . Amgen is currently embroiled in two pivotal court cases surrounding patents for its bestselling etanercept ...

Medicare was authorized to negotiate prices it will pay for Part D drugs. Enbrel, the original version of etanercept, was among the first 10 drugs to be subject to negotiations. The negotiated price ...

Medicare Part D and Medicare Advantage plans that include drug coverage typically cover Enbrel — a biologic medication used for autoimmune conditions, though coverage and costs can vary among plans.